33
Participants
Start Date
September 30, 2003
Primary Completion Date
June 30, 2015
Study Completion Date
June 30, 2015
Fludarabine
25 mg/m\^2 Given By Vein Daily for 5 Days Prior to Allogeneic Transplant.
Melphalan
70 mg/m\^2 Given By Vein Daily for 2 Days Prior to Allogeneic Transplant.
Allogeneic Transplant
Allogeneic transplant given by vein after completion of Fludarabine and Melphalan.
Thymoglobulin
2 mg/kg/day by vein on days -3, -2 and -1 for patients receiving matched unrelated marrow/stem cells or mismatched related marrow.
University of Texas MD Anderson Cancer Center, Houston
M.D. Anderson Cancer Center
OTHER